share_log

Moderna | 4: Statement of changes in beneficial ownership of securities-Officer Klinger Shannon Thyme

SEC announcement ·  Jun 12 04:09
Summary by Futu AI
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock, as per the latest filings. On June 7, 2024, Klinger acquired a total of 10,247 shares through the exercise of derivative securities. Subsequently, on June 10, 2024, she sold 5,178 shares in the open market at a price of $148.0851 per share, resulting in a total sale value of approximately $766,784.65. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 15,947 shares. The transactions were carried out over a period from June 7 to June 10, 2024, and have been reported as completed.
Moderna's Chief Legal Officer, Shannon Thyme Klinger, completed a series of transactions involving the company's common stock, as per the latest filings. On June 7, 2024, Klinger acquired a total of 10,247 shares through the exercise of derivative securities. Subsequently, on June 10, 2024, she sold 5,178 shares in the open market at a price of $148.0851 per share, resulting in a total sale value of approximately $766,784.65. Following these transactions, Klinger's direct holdings in Moderna common stock amounted to 15,947 shares. The transactions were carried out over a period from June 7 to June 10, 2024, and have been reported as completed.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.